Estados Unidos

Mercado internacional de ações

Cadastro completo das bolsas americanas, histórico de preços, demonstrações financeiras, indicadores, rentabilidade, crescimento, endividamento, qualidade, mercado e dividendos.

Ações ordinárias, common stocks e ADRs/ADSs ativos; ETFs, units, warrants, direitos e preferenciais ficam fora desta aba.

Explorar REITs americanos

5.660

ações no escopo

5.646

ligadas à SEC

5.651

com preços

5.119

com fundamentos

18/09/2026

última cotação

SEC como fonte principal

Identidade regulatória, demonstrações anuais e trimestrais e dividendos declarados vêm do EDGAR/XBRL.

Cadastro oficial

Nasdaq Trader cobre Nasdaq, NYSE, NYSE American, NYSE Arca, Cboe e IEX.

Proveniência explícita

A janela pública da Nasdaq tem prioridade; Yahoo Finance completa o período anterior sem ser rotulado como oficial.

Destaques do mercado

Ranking de Stocks

Listas objetivas calculadas sobre todo o universo de ações dos EUA, com preços de mercado e fundamentos SEC.

Top 5

Todas as ações

502 resultados

Ação	Bolsa	Preço	Valor de mercado	P/L

HYFTMindWalk Holdings Corp. - Common Stock	NASDAQ	US$ 1,31	US$ 60,23 mi	—	2,55x	-127,97%	—	Preço 11/09/2026 SEC 30/04/2025
INOInovio Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 1,25	US$ 58,61 mi	—	2,43x	-352,53%	—	Preço 11/09/2026 SEC 31/12/2025
GANXGain Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,75	US$ 57,69 mi	—	3,11x	-108,60%	—	Preço 11/09/2026 SEC 31/12/2025
SPRCSciSparc Ltd. - Ordinary Shares	NASDAQ	US$ 5,08	US$ 55,01 mi	3,97x	6,15x	-83,59%	—	Preço 11/09/2026 SEC 31/12/2024
HRTXHeron Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,32	US$ 53,35 mi	—	3,72x	-140,90%	—	Preço 11/09/2026 SEC 31/12/2025
VRCAVerrica Pharmaceuticals Inc. - Common Stock	NASDAQ	US$ 4,91	US$ 52,30 mi	—	2,11x	-72,29%	—	Preço 11/09/2026 SEC 31/12/2025
OSTXOS Therapies Incorporated Common Stock	NYSE American	US$ 1,68	US$ 49,15 mi	—	-8,06x	471,71%	—	Preço 11/09/2026 SEC 31/12/2025
GTBPGT Biopharma, Inc. - Common Stock	NASDAQ	US$ 8,61	US$ 47,47 mi	—	8,20x	-489,96%	—	Preço 11/09/2026 SEC 31/12/2025
FTHFaeth Therapeutics, Inc. - Common Stock	NASDAQ	US$ 37,44	US$ 47,20 mi	—	2,54x	-113,41%	—	Preço 11/09/2026 SEC 31/12/2025
HOWLWerewolf Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,98	US$ 45,97 mi	—	1,85x	-245,20%	—	Preço 11/09/2026 SEC 31/12/2025
MCRBSeres Therapeutics, Inc. - Common Stock	NASDAQ	US$ 5,01	US$ 44,44 mi	7,83x	1,00x	12,88%	—	Preço 11/09/2026 SEC 31/12/2025
OKUROnKure Therapeutics, Inc. - Class A Common Stock	NASDAQ	US$ 3,10	US$ 41,90 mi	—	0,75x	-105,93%	—	Preço 11/09/2026 SEC 31/12/2025
MAIAMAIA Biotechnology, Inc. Common Stock	NYSE American	US$ 1,30	US$ 41,75 mi	—	17,57x	-942,65%	—	Preço 11/09/2026 SEC 31/12/2025
SPRBSpruce Biosciences, Inc. - Common Stock	NASDAQ	US$ 53,70	US$ 41,17 mi	—	0,97x	-91,65%	—	Preço 11/09/2026 SEC 31/12/2025
ATNMActinium Pharmaceuticals, Inc. (Delaware) Common Stock	NYSE American	US$ 1,22	US$ 38,06 mi	—	4,86x	-432,56%	—	Preço 18/09/2026 SEC 31/12/2025
FLNAFilana Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,77	US$ 37,31 mi	—	0,50x	-122,27%	—	Preço 11/09/2026 SEC 31/12/2025
TELOTelomir Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 1,17	US$ 37,03 mi	—	6,26x	-176,10%	—	Preço 14/09/2026 SEC 31/12/2025
BHSTBioHarvest Sciences Inc. - Common Stock	NASDAQ	US$ 1,63	US$ 36,95 mi	—	1,45x	-43,76%	—	Preço 18/09/2026 SEC 31/12/2025
GRCEGrace Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,22	US$ 36,65 mi	—	0,57x	-12,20%	—	Preço 11/09/2026 SEC 31/03/2026
NERVMinerva Neurosciences, Inc - Common Stock	NASDAQ	US$ 4,15	US$ 35,12 mi	—	-0,25x	208,47%	—	Preço 11/09/2026 SEC 31/12/2025
CNTXContext Therapeutics Inc. - Common Stock	NASDAQ	US$ 0,37	US$ 35,03 mi	—	0,58x	-59,73%	—	Preço 18/09/2026 SEC 31/12/2025
DMRADamora Therapeutics, Inc. - Ordinary Shares	NASDAQ	US$ 24,75	US$ 33,73 mi	6,22x	0,14x	-87,29%	0,00%	Preço 15/09/2026 SEC 31/12/2025
CELUCelularity Inc. - Class A Common Stock	NASDAQ	US$ 1,31	US$ 33,53 mi	—	-0,88x	240,96%	—	Preço 18/09/2026 SEC 31/12/2025
KAPAKairos Pharma, Ltd. Common Stock	NYSE American	US$ 1,76	US$ 32,40 mi	—	5,11x	-85,90%	—	Preço 11/09/2026 SEC 31/12/2025
KYNBKyntra Bio, Inc. - Common Stock	NASDAQ	US$ 7,97	US$ 32,22 mi	0,18x	-1,89x	-1.078,81%	—	Preço 11/09/2026 SEC 31/12/2025
ELTXElicio Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,05	US$ 31,39 mi	—	19,19x	-2.418,77%	—	Preço 11/09/2026 SEC 31/12/2025
NSRXNasus Pharma Ltd. Ordinary Shares	NYSE American	US$ 3,40	US$ 30,70 mi	—	11,09x	-211,56%	—	Preço 11/09/2026 SEC 31/12/2025
CALCCalciMedica, Inc. - Common Stock	NASDAQ	US$ 1,92	US$ 28,82 mi	—	-4,34x	445,14%	—	Preço 18/09/2026 SEC 31/12/2025
BGMBGM Group Ltd. - Class A Ordinary Shares	NASDAQ	US$ 0,25	US$ 28,43 mi	—	0,07x	-5,09%	—	Preço 18/09/2026 SEC 30/09/2025
XRTXXORTX Therapeutics Inc. - Common Shares	NASDAQ	US$ 2,07	US$ 26,89 mi	—	1,61x	-9,87%	—	Preço 14/09/2026 SEC 31/12/2021
CINGCingulate Inc. - Common Stock	NASDAQ	US$ 5,24	US$ 26,49 mi	—	10,56x	-894,81%	—	Preço 18/09/2026 SEC 31/12/2025
ERNAErnexa Therapeutics Inc. - Common Stock	NASDAQ	US$ 4,17	US$ 26,27 mi	—	10,94x	-586,59%	—	Preço 11/09/2026 SEC 31/12/2025
EOCNEocene Ltd. - Ordinary Shares	NASDAQ	US$ 3,84	US$ 25,27 mi	1,61x	1,60x	-65,32%	—	Preço 11/09/2026 SEC 31/12/2025
TXMDTherapeuticsMD, Inc. - Common Stock	NASDAQ	US$ 2,16	US$ 24,99 mi	—	0,93x	-2,12%	—	Preço 11/09/2026 SEC 31/12/2025
PMNProMIS Neurosciences Inc. - Common Shares	NASDAQ	US$ 13,56	US$ 23,82 mi	—	-18,93x	3.155,84%	—	Preço 11/09/2026 SEC 31/12/2025
ANVSAnnovis Bio, Inc. Common Stock	NYSE	US$ 1,14	US$ 23,43 mi	—	1,39x	-171,23%	—	Preço 18/09/2026 SEC 31/12/2025
ABVCABVC BioPharma, Inc. - Common Stock	NASDAQ	US$ 1,16	US$ 23,33 mi	—	1,75x	-59,47%	—	Preço 18/09/2026 SEC 31/12/2025
SERSerina Therapeutics, Inc. Common Stock	NYSE American	US$ 2,22	US$ 22,62 mi	—	-611,40x	51.843,24%	—	Preço 11/09/2026 SEC 31/12/2025
IGCIGC Pharma, Inc. Common Stock	NYSE American	US$ 0,28	US$ 21,32 mi	—	3,37x	-112,51%	—	Preço 11/09/2026 SEC 31/03/2025
ACTUActuate Therapeutics, Inc. - Common stock	NASDAQ	US$ 0,98	US$ 20,63 mi	—	2,60x	-280,51%	—	Preço 18/09/2026 SEC 31/12/2025
RNTXRein Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,79	US$ 19,97 mi	—	1,18x	-294,78%	0,00%	Preço 11/09/2026 SEC 31/12/2025
APUSApimeds Pharmaceuticals US, Inc. Common Stock	NYSE American	US$ 1,77	US$ 19,26 mi	—	0,13x	-3,91%	—	Preço 18/09/2026 SEC 31/12/2025
ATOSAtossa Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,22	US$ 19,12 mi	—	0,49x	-88,35%	—	Preço 18/09/2026 SEC 31/12/2025
LTRNLantern Pharma Inc. - Common Stock	NASDAQ	US$ 1,74	US$ 18,93 mi	—	2,90x	-262,00%	—	Preço 14/09/2026 SEC 31/12/2025
NXTCNextCure, Inc. - Common Stock	NASDAQ	US$ 6,52	US$ 18,53 mi	—	0,53x	-159,81%	0,00%	Preço 14/09/2026 SEC 31/12/2025
MRKRMarker Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,15	US$ 17,61 mi	—	1,05x	-72,42%	—	Preço 11/09/2026 SEC 31/12/2025
SILOSilo Pharma, Inc. - Common Stock	NASDAQ	US$ 2,10	US$ 17,60 mi	—	2,79x	-67,05%	—	Preço 11/09/2026 SEC 31/12/2025
HYPDHyperion DeFi, Inc. - Common Stock	NASDAQ	US$ 3,49	US$ 17,45 mi	—	0,43x	-110,36%	—	Preço 11/09/2026 SEC 31/12/2025
NMADNomad Power Solutions, Inc. - Common Stock	NASDAQ	US$ 3,46	US$ 16,75 mi	—	1,53x	-55,45%	—	Preço 14/09/2026 SEC 31/12/2025
NNVCNanoViricides, Inc. Common Stock	NYSE American	US$ 1,07	US$ 16,17 mi	—	2,15x	-125,93%	—	Preço 14/09/2026 SEC 30/06/2025
NCELNewcelX Ltd. - Ordinary Shares	NASDAQ	US$ 3,30	US$ 15,85 mi	1,53x	2,19x	-114,48%	—	Preço 11/09/2026 SEC 31/12/2025
TVRDTvardi Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,87	US$ 14,55 mi	—	0,69x	-86,96%	0,00%	Preço 11/09/2026 SEC 31/12/2025
PDSBPDS Biotechnology Corporation - Common Stock	NASDAQ	US$ 0,29	US$ 13,68 mi	—	1,48x	-372,85%	—	Preço 11/09/2026 SEC 31/12/2025
COCPCocrystal Pharma, Inc. - Common Stock	NASDAQ	US$ 1,21	US$ 13,66 mi	—	2,16x	-139,49%	—	Preço 18/09/2026 SEC 31/12/2025
BFRIBiofrontera Inc. - Common Stock	NASDAQ	US$ 1,32	US$ 13,43 mi	—	1,28x	-100,53%	—	Preço 18/09/2026 SEC 31/12/2025
LSTALisata Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,53	US$ 13,29 mi	—	0,91x	-113,59%	—	Preço 14/09/2026 SEC 31/12/2025
ASBPAspire-Lakewood Holdings, Inc. - Common Stock	NASDAQ	US$ 8,54	US$ 12,77 mi	—	-2,00x	383,93%	—	Preço 18/09/2026 SEC 31/12/2025
LPCNLipocine Inc. - Common Stock	NASDAQ	US$ 2,15	US$ 12,27 mi	—	0,85x	-66,50%	—	Preço 14/09/2026 SEC 31/12/2025
BIVIBioVie Inc. - Common stock	NASDAQ	US$ 1,61	US$ 11,67 mi	—	1,14x	-214,92%	—	Preço 18/09/2026 SEC 30/06/2026
KPRXKiora Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 2,65	US$ 10,88 mi	—	0,67x	-67,19%	—	Preço 11/09/2026 SEC 31/12/2025
RKTORocket One Inc. - Common Stock	NASDAQ	US$ 0,71	US$ 9,74 mi	—	1,58x	-202,73%	—	Preço 14/09/2026 SEC 31/12/2025
DWTXDogwood Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,94	US$ 9,66 mi	—	0,13x	-45,74%	—	Preço 11/09/2026 SEC 31/12/2025
GDTCCytoMed Therapeutics Limited - Ordinary Shares	NASDAQ	US$ 0,78	US$ 9,25 mi	—	1,35x	-58,31%	—	Preço 11/09/2026 SEC 31/12/2025
VTGNVistagen Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,24	US$ 9,02 mi	—	0,25x	-196,19%	—	Preço 11/09/2026 SEC 31/03/2026
XCURExicure, Inc. - Common Stock	NASDAQ	US$ 1,40	US$ 8,82 mi	—	2,25x	-125,98%	—	Preço 11/09/2026 SEC 31/12/2025
CYTKCytokinetics, Incorporated - Common Stock	NASDAQ	US$ 69,31	US$ 8,32 mi	—	-0,01x	119,00%	—	Preço 15/09/2026 SEC 31/12/2025
DAREDare Bioscience, Inc. - Common Stock	NASDAQ	US$ 0,73	US$ 8,16 mi	—	2,87x	-471,37%	—	Preço 15/09/2026 SEC 31/12/2025
QUCYQuantum Cyber N.V. - Ordinary Shares	NASDAQ	US$ 1,34	US$ 8,03 mi	—	12,51x	-2.526,61%	—	Preço 14/09/2026 SEC 31/12/2025
LITSLite Strategy, Inc. - Common Stock	NASDAQ	US$ 1,11	US$ 7,40 mi	—	0,44x	-94,18%	—	Preço 11/09/2026 SEC 30/06/2025
BOLTBolt Biotherapeutics, Inc. - Common Stock	NASDAQ	US$ 3,56	US$ 6,66 mi	—	0,25x	-125,92%	—	Preço 18/09/2026 SEC 31/12/2025
XBIOXenetic Biosciences, Inc. - Common Stock	NASDAQ	US$ 3,90	US$ 6,64 mi	—	0,90x	-36,25%	—	Preço 11/09/2026 SEC 31/12/2025
PTNPalatin Technologies, Inc. - Common Stock	NASDAQ	US$ 11,80	US$ 6,35 mi	—	-1,33x	362,30%	—	Preço 11/09/2026 SEC 30/06/2025
ALZNAlzamend Neuro, Inc. - Common Stock	NASDAQ	US$ 1,89	US$ 6,31 mi	—	8,60x	-1.196,43%	—	Preço 18/09/2026 SEC 30/04/2026
CLRBCellectar Biosciences, Inc. - Common Stock	NASDAQ	US$ 2,38	US$ 6,21 mi	—	0,73x	-255,25%	—	Preço 18/09/2026 SEC 31/12/2025
CTXRCitius Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 0,56	US$ 6,20 mi	—	0,08x	—	—	Preço 15/09/2026 SEC 30/09/2025
NEUPNeuphoria Therapeutics Inc. - Common Stock	NASDAQ	US$ 3,73	US$ 6,05 mi	—	0,32x	-1,95%	—	Preço 11/09/2026 SEC 30/06/2025
CANFCan-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares	NYSE American	US$ 2,24	US$ 5,87 mi	—	1,05x	-175,75%	—	Preço 18/09/2026 SEC 31/12/2025
SHPHShuttle Pharmaceuticals Holdings, Inc. - common stock	NASDAQ	US$ 3,53	US$ 5,78 mi	—	2,56x	-519,94%	—	Preço 11/09/2026 SEC 31/12/2025
INMInMed Pharmaceuticals Inc. - Common Shares	NASDAQ	US$ 1,29	US$ 5,37 mi	—	5,00x	-1.168,44%	—	Preço 11/09/2026 SEC 30/06/2026
SCNXScienture Holdings, Inc. - Common Stock	NASDAQ	US$ 0,35	US$ 5,34 mi	—	0,08x	-59,20%	—	Preço 11/09/2026 SEC 31/12/2025
PULMPulmatrix, Inc. - Common Stock	NASDAQ	US$ 1,41	US$ 5,15 mi	—	1,35x	-135,49%	—	Preço 11/09/2026 SEC 31/12/2025
APREAprea Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,76	US$ 4,97 mi	—	0,40x	-101,27%	—	Preço 18/09/2026 SEC 31/12/2025
BFRGBullfrog AI Holdings, Inc. - Common Stock	NASDAQ	US$ 0,46	US$ 4,79 mi	—	2,24x	-304,17%	—	Preço 18/09/2026 SEC 31/12/2025
TRAWTraws Pharma, Inc. - Common Stock	NASDAQ	US$ 0,56	US$ 4,73 mi	0,69x	-7,51x	-1.457,87%	—	Preço 11/09/2026 SEC 31/12/2025
HCWBHCW Biologics Inc. - Common Stock	NASDAQ	US$ 2,24	US$ 4,70 mi	—	1,70x	-287,90%	—	Preço 11/09/2026 SEC 31/12/2025
KALAKALA BIO, Inc. - Common Stock	NASDAQ	US$ 0,57	US$ 4,66 mi	—	0,67x	-385,65%	—	Preço 11/09/2026 SEC 31/12/2025
HINDVyome Holdings, Inc. - Common Stock	NASDAQ	US$ 2,06	US$ 4,45 mi	—	1,18x	-272,78%	—	Preço 11/09/2026 SEC 31/12/2025
ARTLArtelo Biosciences, Inc. - Common Stock	NASDAQ	US$ 3,94	US$ 4,05 mi	—	-3,19x	1.012,50%	—	Preço 18/09/2026 SEC 31/12/2025
KTTAPasithea Therapeutics Corp. - Common Stock	NASDAQ	US$ 0,53	US$ 3,73 mi	—	0,07x	-36,99%	—	Preço 11/09/2026 SEC 31/12/2025
PPCBPropanc Biopharma, Inc. - Common Stock	NASDAQ	US$ 0,92	US$ 3,65 mi	—	0,26x	-423,72%	—	Preço 11/09/2026 SEC 30/06/2025
TPSTTempest Therapeutics, Inc. - Common Stock	NASDAQ	US$ 0,81	US$ 3,37 mi	—	0,51x	-393,85%	—	Preço 11/09/2026 SEC 31/12/2025
ADILAdial Pharmaceuticals, Inc - Common Stock	NASDAQ	US$ 4,86	US$ 3,25 mi	—	0,62x	-151,18%	—	Preço 18/09/2026 SEC 31/12/2025
IMNNImunon, Inc. - Common Stock	NASDAQ	US$ 1,47	US$ 3,12 mi	—	0,44x	-205,26%	—	Preço 11/09/2026 SEC 31/12/2025
PBMPsyence Biomedical Ltd. - Common Shares	NASDAQ	US$ 5,40	US$ 3,07 mi	1,03x	0,46x	15,05%	—	Preço 11/09/2026 SEC 31/03/2025
TOVXTheriva Biologics, Inc. Common Stock	NYSE American	US$ 0,25	US$ 3,01 mi	—	0,20x	—	—	Preço 11/09/2026 SEC 31/12/2025
TCRTAlaunos Therapeutics, Inc. - Common Stock	NASDAQ	US$ 1,51	US$ 2,94 mi	—	1,37x	-193,96%	—	Preço 11/09/2026 SEC 31/12/2025
MTVAMetaVia Inc. - Common Stock	NASDAQ	US$ 1,66	US$ 2,93 mi	—	0,55x	-243,26%	—	Preço 11/09/2026 SEC 31/12/2025
MDCXMedicus Pharma Ltd. - Common Stock	NASDAQ	US$ 0,16	US$ 2,81 mi	—	75,32x	-126.722,72%	—	Preço 11/09/2026 SEC 31/12/2025
PCSAProcessa Pharmaceuticals, Inc. - Common Stock	NASDAQ	US$ 2,08	US$ 2,72 mi	—	0,49x	-243,20%	—	Preço 11/09/2026 SEC 31/12/2025
INDPIndaptus Therapeutics, Inc. - Common Stock	NASDAQ	US$ 2,77	US$ 2,68 mi	—	0,85x	-661,54%	—	Preço 11/09/2026 SEC 31/12/2025

Mercado internacional de ações

Ranking de Stocks

Mais populares

Todas as ações

Maiores lucros

Maiores ROEs

Maiores altas